We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 307

Eli Lilly’s Cialis patent withstands double patenting and utility challenges on appeal
  • Gowling WLG
  • Canada
  • April 26 2016

The Federal Court of Appeal has provided guidance on the law of obviousness-type double patenting in dismissing Mylan’s appeal pertaining to Eli


Patent owner’s entitlement to permanent injunction in Canada confirmed
  • Gowling WLG
  • Canada
  • April 21 2016

In Uponor AB v. Heatlink Group Inc. et al., 2016 FC 320 ("Uponor"), the Federal Court of Canada awarded a permanent injunction after a finding that


Approvability of generic NOC satisfies imminence criteria in quia timet proceedings
  • Gowling WLG
  • Canada
  • April 7 2016

The Federal Court in Gilead Sciences Inc v Teva Canada Limited, 2016 FC 336 has clarified the law with respect to the imminence requirement of future


Patent law: 2015 year in review
  • Gowling WLG
  • Canada
  • April 6 2016

A successful patentee in a patent infringement action is entitled to monetary compensation in relation to acts of infringement. In this regard, the


The final word on the claim for innovator profits following PM(NOC) litigation?
  • Gowling WLG
  • Canada
  • March 31 2016

Generic pharmaceutical companies have long sought the disgorgement of innovator profits following litigation under the Patented Medicines (Notice of


Federal Court deviates from established tests for patent listing Gilead Sciences, Inc. v. Canada (Health)
  • Gowling WLG
  • Canada
  • March 22 2016

In the decision summarized below, Apotex successfully obtained a dismissal of Gilead's application for a prohibition order in respect of Canadian


Supreme Court of Canada to consider law of utility in Esomeprazole appeal
  • Gowling WLG
  • Canada
  • March 11 2016

The Supreme Court of Canada has again acknowledged the need to consider the law of utility in Canada by granting Astrazeneca leave to appeal in


Applications for leave to appeal dismissed - 14 January 2016
  • Gowling WLG
  • Canada
  • January 14 2016

The respondent was a first-time, non-violent federal offender who was sentenced after the repeal of accelerated parole review (“APR”) for offences


Canadian patent law: 2015 year in review
  • Gowling WLG
  • Canada
  • January 13 2016

A successful patentee in a patent infringement action is entitled to monetary compensation in relation to the acts of infringement. In this regard


Patentability in Canada
  • Gowling WLG
  • Canada, Global
  • January 11 2016

A structured guide to patents law and practice in Canada